Global Mental Illnesses Market - Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • Sep 2019
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Mental Illnesses Market By Mental Disorders (Clinical depression, Anxiety, Bipolar, Dementia, Attention-deficit/hyperactivity disorder, Schizophrenia, OCD, Autism, Post-traumatic stress), Diagnosis (Psychological Test, Lab Tests, Depression Screening Tests), Treatment (Psychotherapy, Medication), By End User (Hospitals, Medical Research Centers), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Market Analysis: Global Mental Illnesses Market

Global mental illnesses market is set to witness a Substantial CAGR in the forecasted period of 2019-2026; the report contains data from the base year of 2018 and the historic year of 2017. The rise in the market value can be attributed to rising publicity of mental disorders, social and environmental changes.

Market Definition: Global Mental Illnesses Market

Mental illness additionally referred to as mental state disorders, refers to a good vary of mental state conditions — disorders that have an effect on your mood, thinking and behavior. Samples of psychopathy embrace depression, anxiety disorders, psychosis, consumption disorders and addictive behaviors. Many people have mental state issues from time to time. However a mental state concern becomes a psychopathy once in progress signs and symptoms cause frequent stress and have an effect on your ability to perform.

Market Drivers

  • Increased in publicity of mental disorders is contributing to the growth of the market
  • Social and environmental changes, at the side of ever-changing style is boosting the growth of the market,
  • Rise in adoption of latest therapies and coverings is propelling the growth of the market
  • Increasing awareness concerning disorders and covering is driving the growth of the market,

Market Restraints

  • Increasing in senior citizen population

Segmentation: Global Mental Illnesses Market

By Mental Disorders

  • Clinical depression
  • Anxiety
  • Bipolar
  • Dementia
  • Attention-deficit/hyperactivity disorder
  • Schizophrenia
  • OCD
  • Autism
  • Post-traumatic stress

By Diagnosis

  • Psychological Test
  • Lab Tests
  • Depression Screening Tests

By Treatment

  • Psychotherapy

    • Cognitive behavioral therapy (CBT)
    • Psychoanalysis
    • Systemic therapy.

  • Medication

    • Drugs
    • Antipsychotics
    • Antidepressants,
    • Antianxiety (Anxiolyitcs)
    • Anti-Seizure Medications
    • Stimulants

By End User

  • Hospitals
  • Medical Research Centers

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East and Africa

    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In July 2019, Bright Quest San Diego offers ongoing treatment in Bright Quest San Diego, a long-term therapeutic center for persons with complex psychiatric disease, including treatment, transition, half-independent livelihoods, outpatient treatment, and household and community counselling. Work in the particular industry has been granted the Gold Seal of Accreditation of the Joint Commission for Accreditation of Conduct Health Care by demonstrating compliance with its standards of performance. The Gold Seal approval could be a quality image of AN's commitment to safe and effective therapy.
  • In August 2018The IRDAI has instructed all insurance companies to develop a clause for hiding the psychological state together in insurance policies. The 2017 mental health act, in power w.e.f 29.5.2018, is referred to here. According to Section 21(4) of this Act, each health underwriter shall provide a medical benefit scheme on the same grounds as is obtainable to treat physical illness for psychiatric illness, psychiatric illness, psychopathy, psychological status, and psychological condition}.

Competitive Analysis:

Global mental illnesses market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Mental Illnesses Market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major market competitors currently working in the Global mental illnesses market are Johnson & Johnson Services Inc., AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company. F-Hoffmann-La Roche Ltd, Novartis AG, Otsuka Holdings Co., Ltd., Pfizer Inc., GlaxoSmithKline plc , Alkermes , ALLERGAN, Janssen Pharmaceuticals, Inc. ,Solvay Meiji Holdings Co, Ltd., Abbott ,Jazz Pharmaceuticals, Inc ,AbbVie Inc. ,Vertical Pharmaceuticals, LLC ,ACADIA Pharmaceuticals Inc. ,Medtronic Bausch Health ,Alfasigma USA Inc. ,Merck KGaA ,Island Health, Homewood Health, Inc. ,ROYAL OTTAWA HEALTH CARE GROUP, CAMH, Substance Abuse and Mental Health Service Administration (SAMSHA), National Institute of Mental Health (NIMH) Validus Pharmaceuticals LLC

Research Methodology:  Global Mental Illnesses Market

 Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of Global mental illnesses market  outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19